From: Ex vivo observation of granulocyte activity during thrombus formation
 | EDTA | Citrate | Citrate recalcified | Heparin | Hirudin |
---|---|---|---|---|---|
NC velocity, μm/s | |||||
 Minimal instant | 0.072 ± 0.022 | 0.07 ± 0.06 | 0.022 ± 0.003 | 0.018 ± 0.005 | 0.022 ± 0.017 |
 Maximal instant | 0.65 ± 0.14 | 0.58 ± 0.14 | 0.62 ± 0.03 | 0.567 ± 0.07 | 0.703 ± 0.006 |
 Average | 0.30 ± 0.09 | 0.32 ± 0.07 | 0.137 ± 0.018 | 0.095 ± 0.012 | 0.116 ± 0.017 |
NС trajectory length, μm | |||||
 Minimal | 30 ± 21 | 24 ± 11 | 30 ± 7 | 23 ± 9 | 26 ± 15 |
 Maximal | 221 ± 69 | 228 ± 40 | 361 ± 114 | 400 ± 67 | 469 ± 25 |
 Median | 82 ± 46 | 65 ± 35 | 148 ± 62 | 137 ± 9 | 216 ± 44 |
Motionless NCs (velocity < 0.045 μm/s), % | – | – | 25 ± 13 | 15 ± 5 | 7 ± 4 |
Number of attached NCs per FOV | – | – | 0.52 ± 0.23 | 1.6 ± 0.6 | 1.1 ± 0.6 |
Thrombus area, % of FOV | 3.6 ± 2.3 | 21 ± 3 | 19.9 ± 2.2 | 9.7 ± 0.9 | 12 ± 4 |